Sumitomo Pharma, suffering from sliding sales, lays off another 400 US staffers

Sumitomo Pharma’s hundeds of layoffs last summer weren't enough for the struggling company to stem the tide as its revenues decline and its bond prices crater.

Now, the Japanese drugmaker is letting go of 400 staffers this month.